Schedule of Pharmaceutical Benefits - 1 September 2023

1 September 2023 - The September 2023 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

Global sarcoma therapy now listed on Pharmaceutical Benefits Scheme

31 July 2023 - Yondelis (trabectedin) demonstrates 45% reduction in risk of disease progression or death versus dacarbazine. ...

Read more →

Schedule of Pharmaceutical Benefits - 1 August 2023

1 August 2023 - The August 2023 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

PBS subsidy arrangements for insulin degludec and insulin aspart

7 July 2023 - The Department of Health and Aged Care has made amendments to the National Health (Pharmaceutical Benefits) (Pharmacist ...

Read more →

Widened eligibility for oral antiviral Paxlovid, plus new medicines on PBS

2 July 2023 - From 1 July 2023, Australians with severe thrombocytopenia and diabetic kidney disease will have access to ...

Read more →

Schedule of Pharmaceutical Benefits - 1 July 2023

1 July 2023 - The July 2023 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

Changes to the National Immunisation Program effective 1 July 2023

30 June 2023 - From 1 July 2023, Vaxelis will be added to the National Immunisation Program as an alternative ...

Read more →

Breast cancer survivor wants $7,000 a month wonder drug to be more readily available to patients

23 June 2023 - A young Wollongong mother has spoken about her "remarkable" recovery from a breast cancer that had ...

Read more →

Australian health insurers and pharmaceutical companies reckon with new psychedelic mental health treatments

17 June 2023 - Medicinal cannabis companies are trying to get a foothold in Australia's new psychedelics market, with therapies ...

Read more →

Calls for more medicinal cannabis brands to be added to Pharmaceutical Benefits Scheme as costs surge

8 June 2023 - Jukka Manttari is pain-free for the first time in 30 years thanks to medicinal cannabis, but ...

Read more →

Antengene announces Xpovio plus bortezomib and dexamethasone included for reimbursement by the PBS in Australia for the treatment of relapsed and/or refractory multiple myeloma

31 May 2023 - This inclusion by the PBS for the treatment of patients with relapsed and/or refractory multiple myeloma who ...

Read more →

RACGP opposes GLP-1 RA prescribing restrictions

30 May 2023 - Changing the authority type for initiating the diabetes medication will make it difficult for ‘already burdened’ GPs ...

Read more →

Schedule of Pharmaceutical Benefits - 1 June 2023

1 June 2023 - The June 2023 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

Australians battling with prostate cancer to benefit from new PBS listing

25 May 2023 - Australians battling prostate cancer that has spread past the prostate will soon benefit from subsidised medicine ...

Read more →

New life changing treatment for dwarfism added to PBS

24 May 2023 - Children born with the most common form of dwarfism will have access to a new life ...

Read more →